These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 34937821)
21. An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population. Zhang Y; Liu K; Li W; Xue Q; Hong J; Xu J; Wu L; Ji G; Sheng J; Wang Z J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1179-83. PubMed ID: 27475733 [TBL] [Abstract][Full Text] [Related]
22. Titrated versus conventional anticoagulation management for thrombin generation in cardiac surgery: a randomized controlled trial. Li H; Bartoszko J; Serrick C; Rao V; Karkouti K Can J Anaesth; 2022 Sep; 69(9):1117-1128. PubMed ID: 35799088 [TBL] [Abstract][Full Text] [Related]
23. Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study. Radulovic V; Laffin A; Hansson KM; Backlund E; Baghaei F; Jeppsson A PLoS One; 2015; 10(7):e0130271. PubMed ID: 26134993 [TBL] [Abstract][Full Text] [Related]
24. Hemostasis management by use of Hepcon/HMS: increased bleeding without increased need for blood transfusion. Beholz S; Grubitzsch H; Bergmann B; Wollert HG; Eckel L Thorac Cardiovasc Surg; 1999 Oct; 47(5):322-7. PubMed ID: 10599961 [TBL] [Abstract][Full Text] [Related]
25. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial. Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705 [TBL] [Abstract][Full Text] [Related]
26. Heparin monitoring during cardiac surgery. Part 1: Validation of whole-blood heparin concentration and activated clotting time. Raymond PD; Ray MJ; Callen SN; Marsh NA Perfusion; 2003 Sep; 18(5):269-76. PubMed ID: 14604242 [TBL] [Abstract][Full Text] [Related]
31. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery. Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066 [TBL] [Abstract][Full Text] [Related]
32. Less is more: We are administering too much protamine in cardiac surgery. De Simone F; Nardelli P; Licheri M; Frau G; Redaelli MB; Monaco F; Zangrillo A; Landoni G Ann Card Anaesth; 2021; 24(2):178-182. PubMed ID: 33884973 [TBL] [Abstract][Full Text] [Related]
33. Response to heparinization in adults and children undergoing cardiac operations. Horkay F; Martin P; Rajah SM; Walker DR Ann Thorac Surg; 1992 May; 53(5):822-6. PubMed ID: 1570978 [TBL] [Abstract][Full Text] [Related]
34. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. Jobes DR; Aitken GL; Shaffer GW J Thorac Cardiovasc Surg; 1995 Jul; 110(1):36-45. PubMed ID: 7609566 [TBL] [Abstract][Full Text] [Related]
35. Management of a Patient With Antiphospholipid Syndrome Undergoing Aortic Valve Replacement Using the Hepcon Hemostasis Management System Plus and Rotational Thromboelastometry: A Case Report. Samejima Y; Kodaka M; Ichikawa J; Mori T; Ando K; Nishiyama K; Komori M A A Case Rep; 2017 Mar; 8(5):100-104. PubMed ID: 28098662 [TBL] [Abstract][Full Text] [Related]
36. A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass. Li H; Serrick C; Rao V; Yip PM Perfusion; 2021 Sep; 36(6):610-619. PubMed ID: 32885714 [TBL] [Abstract][Full Text] [Related]
37. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Spitznagel E; Cox JL; Lappas DG J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1076-82. PubMed ID: 7983877 [TBL] [Abstract][Full Text] [Related]
38. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass. Gautam NK; Schmitz ML; Harrison D; Zabala LM; Killebrew P; Belcher RH; Prodhan P; McKamie W; Norvell DC Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140 [TBL] [Abstract][Full Text] [Related]
39. Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration. Pappalardo F; Franco A; Crescenzi G; De Simone F; Torracca L; Zangrillo A Perfusion; 2006 Dec; 21(5):285-90. PubMed ID: 17201083 [TBL] [Abstract][Full Text] [Related]
40. Changes in heparin dose response slope during cardiac surgery: possible result in inaccuracy in predicting heparin bolus dose requirement to achieve target ACT. Ichikawa J; Mori T; Kodaka M; Nishiyama K; Ozaki M; Komori M Perfusion; 2017 Sep; 32(6):474-480. PubMed ID: 28820035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]